Gastroenterology Learning Network

Guest Michael Dolinger, MD, from the Icahn School of Medicine at Mount Sinai, talk to host Millie Long, MD, about the use and advantages of intestinal ultrasound for monitoring inflammatory bowel disease.

In this episode of IBD Drive Time, guest host David Rubin, MD, calls on Drs Severine Vermeire of KU Leuven University in Belgium and Dan Tucker of Hebrew University of Jerusalem to talk about the challenges of recruiting patients for clinical trials in inflammatory bowel disease and the ethical issues involved.

Dr Scott discusses the development of a pathway based on specific diagnostic criteria that indicate the need to refer patients with inflammatory bowel disease to specialist centers.

In the latest IBD Drive Time, host Raymond Cross, MD, talks with Ryan Stidham, MD, about potential applications for artificial intelligence and ChatGPT in gastroenterology practice—and what is feasible right now.

Drs Brian Lacy and Mark Pimentel provide an update on the progress in diagnosing and treating small intestinal bacterial overgrowth and a similar condition, intestinal methanogen overgrowth (IMO).

Dr Edward Loftus reviews details of the pivotal trial where upadacitinib emerged a superior alternative to placebo for induction and maintenance therapy among patients with moderate-to-severe Crohn’s disease.

In this podcast, Dr Adam Faye explains the association between various patient-level demographic, nutritional and clinical factors and risk for complications among older patients who underwent intestinal resection for inflammatory bowel disease. -- Adam Faye, MD, is an assistant professor of medicine and population health at the Inflammatory Bowel Disease Center at NYU Langone Health. --

Dr Gil Melmed from Cedars-Sinai talks with Drs Raymond Cross and Millie Long about the importance of vaccines, cancer screenings, and other aspects of overall health maintenance for patients with inflammatory bowel disease.

IBD Drive Time: Christina Ha, MD, on Biosimilars by Gastroenterology Learning Network

Guest Christina Ha, MD, from the Mayo Clinic in Arizona, reviews key points about the advent of biosimilars, including reassuring patients and countering the "nocebo" effect, with hosts Drs Raymond Cross and Millie Long.

The 2 leading gastrointestinal societies in United States—the American Gastroenterological Association and the American College of Gastroenterology—collaborated to produce guidance on pharmacological agents available for the treatment of chronic idiopathic constipation.

In part 2 of their podcast on Helicobacter pylori, Drs William Chey and Brian Lacy talk about the risks of untreated disease and the various types of treatment available.

In this first of a two-part podcast on Helicobacter pylori, Drs Brian Lacy and William Chey discuss the prevalence of H pylori infection and how to best diagnose the condition.

Dr David Rubin from the University of Chicago discusses the hurdles of prior authorization and ways to manage the process to ensure patients can receive their IBD therapies, with guests David Choi, PharmD, and Mona Shah, MPH.

Dr Gideon Hirschfield from the University of Toronto Centre for Liver Disease discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.

Dr Gideon Hirschfield from the University of Toronto discusses the potential of new drugs, including selective PPAR agents such as seladelpar, for the treatment of primary biliary cholangitis.

Drs Raymond Cross and Millie Long continue their discussion about the best abstracts on inflammatory bowel disease presented at the Digestive Disease Week conference in May.

In the first of two episodes, Drs Millie Long and Raymond Cross discuss their choices of the best abstracts on inflammatory bowel disease from the Digestive Disease Week conference held in May.

In this episode of IBD Drive Time, cohost Raymond Cross, MD, talks with Siddharth Singh, MD, on the new guidelines from the American Gastroenterological Association on caring for patients with ulcerative colitis.

In a special edition of IBD Drive Time, guest host David Rubin, MD, discusses how inflammatory bowel disease can affect sexual function with his University of Chicago colleagues Alyse Bedell, PhD, GI psychologist and sex therapist, and Sarah Macareg, PhD, a pelvic floor physical therapist.

Host Brian Lacy, MD, discusses the challenges of accurately diagnosing and treating exocrine pancreatic insufficiency with guest Santhi Swaroop Vege, MD, from the Mayo Clinic in Rochester, Minnesota.

Gut Check host Brian Lacy, MD, discusses exocrine pancreatic insufficiency, including proper diagnosis and treatment, with pancreatologist Dr Santhi Vege.

In this episode of IBD Drive Time, Drs Millie Long and Raymond Cross talk to Dr Parambir Dulai about abstracts from the ECCO ’23 Congress on the role of biomarkers in the clinical care and research for inflammatory bowel disease.

Elham Afghani, MD, on the Genetic Epidemiology of Pancreatic Cancer by Gastroenterology Learning Network

Dr Barnes reviews key abstracts from ECCO 2023 on novel therapeutics for inflammatory bowel disease with hosts Drs Raymond Cross and Millie Long.